Mykolab FAQ: Magic Mushrooms, Psilocybin and Grow Kits

Magic mushrooms is an informal name for fungi containing psychedelic compounds, most commonly psilocybin and psilocin. It does not describe a single species or a scientifically defined product category. Different mushrooms grouped under this name can vary in their biology and chemical composition.

No. Psilocybin-containing fungi belong to multiple species and genera. Calling them all “magic mushrooms” can hide those differences, much as the word “fruit” covers many different plants.

Psilocybe cubensis is a species of psilocybin-producing fungus. Names such as Golden Teacher and APE refer to cultivated varieties associated with this species, rather than separate species. A species name identifies the organism taxonomically, while a variety name describes a particular cultivated line. Our Psilocybin Mycelium Glossary explains this terminology alongside other mycological terms.

Mycelium is the network of microscopic threads that forms the main body of a fungus. A mushroom is a fruiting body produced by that network.

The distinction matters because the visible mushroom is only part of the organism. Mycelium absorbs nutrients and extends through its surroundings, while fruiting bodies have a reproductive role. Talking about “a mushroom” can therefore mean either the visible structure or, less precisely, the fungus as a whole.

Spores are microscopic reproductive structures involved in fungal reproduction and dispersal. They are different from mycelium, which consists of living fungal threads called hyphae.

No. Fly agaric, Amanita muscaria, has different principal psychoactive compounds: muscimol and ibotenic acid. It should not be treated as interchangeable with psilocybin-containing mushrooms. Using the same informal label for both can create confusion about their chemistry, effects and risks.

They can change sensory perception, emotions and a person’s sense of time or self. Experiences vary, and changes may be distressing rather than pleasant.

No. Concentrations vary between species and individual samples. A variety name, the size of a specimen or an online photograph cannot establish its chemical composition. That requires appropriate analysis of the actual material. This is one reason broad claims about a variety’s “strength” should not be treated as precise measurements.

A photograph alone cannot establish that a mushroom is safe to consume. Psilocybin-containing mushrooms can resemble poisonous species, and mistakes can have serious consequences. An image shared online is not a substitute for expert identification.

No. Natural origin does not establish safety. Psychological distress, impaired judgement and physical side effects can occur, while misidentification adds a separate risk of poisoning.

No. A name cannot reliably predict whether someone will feel relaxed, reflective or anxious. Chemical composition is only part of the picture; expectations, surroundings and individual factors also influence the experience.

This distinction is discussed in our interview with Mykolab founder Piotr Kwiatkowski, which examines how personal stories become attached to particular varieties and later turn into marketing promises.

Personal experiences can raise questions worth researching, but they cannot demonstrate that a substance treats an illness. An improvement may have several explanations, including other treatment, changing circumstances or expectations. In our discussion of science and mushroom myths, we explore the difference between describing an individual experience and promising the same result to someone else.

Psilocybin is a naturally occurring psychedelic compound found in certain fungi. It is a chemical substance, not a mushroom species. The body converts it into psilocin, which produces much of its psychoactive activity.

Psilocybin is a precursor that the body converts into psilocin. Although their names are similar, they are different molecules. Psilocin interacts with serotonin receptors involved in perception and other brain functions. For definitions of both compounds and the conversion process, see our Psilocybin Mycelium Glossary.

After conversion to psilocin, it affects serotonin signalling, particularly through 5-HT2A receptors. This influences brain activity and communication between regions, contributing to changes in perception and consciousness.

Researchers are investigating whether psilocybin, delivered under defined clinical conditions, could help with depression, some substance use disorders and distress associated with serious illness. They also study adverse effects and how long any improvements last. Research interest does not mean every proposed application has been demonstrated to work.

No. Findings from supervised studies do not establish that taking mushrooms independently cures depression. A clinical result applies to the treatment, participants and conditions investigated.

For example, our article on women and psilocybin research discusses a depression study involving psychological support and participant screening. It also explains why findings from general depression research cannot automatically be applied to postpartum depression or symptoms associated with menopause.

A clinical trial follows a research protocol and includes eligibility checks, defined interventions and monitoring. Researchers record outcomes and adverse events rather than relying only on personal impressions.

Those details affect what a study can tell us. A positive result in a screened group does not establish that the intervention is suitable for everyone. Our article on psilocybin research involving women illustrates why study design and participant characteristics matter.

Microdosing means taking small amounts intended to avoid a pronounced psychedelic experience. The term describes a practice, not a clinically established treatment.

There is not enough evidence to present these effects as reliable benefits. Reports of improvement do not, by themselves, show what caused it or establish long-term safety.

Expectations are part of the research question. Someone who anticipates greater creativity may interpret ordinary changes in their working day differently. Our interview about psilocybin research and internet myths discusses this distinction between subjective experience and scientific evidence.

Reported side effects include nausea, headaches, dizziness, anxiety and increased heart rate or blood pressure. Some people experience intense fear, confusion or paranoia. An experience described positively by one person does not establish safety for another.

Yes. Particular concerns apply to psychotic disorders and certain other psychiatric conditions. Screening in research settings is one reason clinical findings should not be interpreted as general advice to self-treat.

Yes. Other substances and medicines may affect responses and risks. Anyone taking prescription medication should discuss interaction concerns with a clinician rather than stopping or adjusting treatment independently.

No. Mykolab’s products are not medicines or medical devices and are not intended for consumption. Our articles provide educational information; they do not replace diagnosis, individual medical advice or treatment. Product classifications are set out in our Terms and Conditions.

Mykolab is a mycology brand focused on laboratory-produced grow kits. Its development began in 2020 with work on product consistency and production processes, before the brand became publicly visible. The About Mykolab page explains that background and how the business developed.

The website is operated by Mykolab B.V., trading as Mykolaborian. Company details are available on the Contact page.

No. Mykolab’s Terms and Conditions describe an online business without a physical retail shop. A registered company address should therefore not be treated as a walk-in store.

Yes. Mykolab specifies that its grow kits are intended for adults aged 18 and over. Visitors are asked to confirm their age before continuing.

No. Mykolab’s terms state that it does not supply mature finished products or products containing controlled substances. Its products are not intended for consumption.

Email contact@mykolab.eu or use the form on our Contact page. Customer service handles enquiries about existing orders, delivery issues, returns and complaints. If your message concerns an existing order, include its number so the team can identify the relevant information.

Include your name, order number where applicable, what happened and when. Explain the assistance you need. For a product issue, photographs and label details can help the team assess the problem without first requesting those details separately. You can submit this information through the contact form.

Send customer service clear photographs of the unopened bag and its label, together with the batch number if one is shown. Add your order number and describe what you noticed. The Contact page explains which details to provide when reporting a grow kit problem.

The published timeframe is a full response within 14 days. If the matter requires longer, the team will explain when to expect an answer.

Mykolab’s published policy excludes perishable grow kits from change-of-mind returns because they are living biological products with a limited shelf life. This is different from reporting a defect. Before requesting a return, consult the Returns and Refunds Policy to understand which provisions apply to your situation.

No. Changing your mind about a purchase and receiving a non-conforming product are different situations.

Mykolab’s return policy preserves rights relating to products that do not comply with the agreement or are affected by contamination. An exclusion from change-of-mind returns therefore does not automatically settle a complaint about a defect. Describe the issue to customer service and refer to the Returns and Refunds Policy for the applicable process.

Start with the Terms and Conditions and Returns and Refunds Policy. The website footer also provides links to privacy information, the complaints procedure and information about withdrawal rights. These documents address different issues, so choose the one relevant to your enquiry.

A grow kit is a prepared biological product containing fungal material and a substrate. In Mykolab’s terminology, it contains mycelium in or on that substrate. It is not the same as a packet of spores or a container of mature mushrooms.

Mykolab’s catalogue includes Golden Teacher, McKennaii, Mazatapec, Enigma, APE, Bluey Vuitton, Makilla Gorilla, Tidal Wave 4, Nutcracker, Jack Rabbit, MVP and Too Big To Handle. This describes the listed range rather than guaranteeing that every item is continuously available.

Not necessarily. Golden Teacher, APE and Enigma are names associated with cultivated varieties or lines of Psilocybe cubensis. Several catalogue names can therefore refer to the same species.

The substrate is the material in or on which mycelium is present. It is part of the kit, not another name for the mushroom itself. Related terms are explained in our mycelium glossary.

Mycelium is the living network of microscopic fungal threads called hyphae. It forms the main body of the fungus, while the familiar mushroom is its fruiting structure. Understanding this distinction makes product descriptions easier to follow. Our Psilocybin Mycelium Glossary explains both terms.

Visit our Articles section, where we discuss fungal biology, mycelium and the terminology used in mycology. You can explore individual topics or start with the glossary for an introduction to unfamiliar terms.

A species is a scientific classification, while a cultivated variety describes a particular line within that species. Organisms belonging to different cultivated varieties can differ in appearance while remaining members of the same species. Recognising these two levels helps you understand how product names relate to fungal biology.

Observation can reveal differences in colour, shape, texture and the arrangement of fungal tissue. These characteristics introduce the concept of morphology: the study of an organism’s physical form.

Recording what is visible also encourages a useful scientific habit: separating an observation from its interpretation. Describing a structure as folded or branching records what you see; explaining why it has that form requires additional evidence.

Our Psilocybin Mycelium Glossary explains terms including mycelium, substrate, spores, fruiting body and cultivated variety. You can use it as a reference whenever an unfamiliar expression appears.

Mykolab’s development began in 2020 with work on product consistency and production processes. The company’s published history describes repeated testing, adjustments and the challenges involved in moving from individual batches to a larger operation.

Visit About Mykolab to discover how that work developed into the brand and the laboratory operation behind it.

Our interview with founder Piotr Kwiatkowski explores the questions behind the brand’s educational content. The conversation covers scientific curiosity, popular misconceptions and the distinction between personal experiences and research findings.

Yes. If a term or specification is unclear, use our Contact page to send your question. Include the product name and the wording you would like explained so the team can address the specific detail.